TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
118 hedge funds and large institutions have $1.07B invested in TCR2 Therapeutics Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
44% more funds holding
Funds holding: 82 → 118 (+36)
6% more call options, than puts
Call options by funds: $3.79M | Put options by funds: $3.59M
Holders
118
Holding in Top 10
3
Calls
$3.79M
Puts
$3.59M
Top Buyers
1 | +$54.5M | |
2 | +$32.8M | |
3 | +$21.3M | |
4 |
State Street
Boston,
Massachusetts
|
+$19.2M |
5 |
BlackRock
New York
|
+$15.4M |
Top Sellers
1 | -$113M | |
2 | -$24.4M | |
3 | -$5.45M | |
4 |
GH
GAM Holding
Zurich,
Switzerland
|
-$3.38M |
5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.09M |